Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
Corinne Castelnau(Inserm), Elyanne Gault(Université Sorbonne Paris Nord), Bach‐Nga Pham(Inserm), Sarah Maylin(Inserm), Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Paul Dény(Université Sorbonne Paris Nord), Emmanuel Gordien(Université Paris Cité), Marie–Pierre Ripault(Inserm), Michelle Martinot-Peignoux(Université Claude Bernard Lyon 1), Frédéric Le Gal(Sorbonne Université), Nathalie Boyer(Inserm), Patrick Marcellin(Inserm)
Cited by 238
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
|New England Journal of Medicine|2004|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
|Gastroenterology|2006|882